FAIRFAX FINANCIAL HOLDINGS LTD/ CAN (FRFHF) Form 6-K — Nov 3, 2026
Fairfax Financial reported Q3 2026 net earnings attributable to shareholders of $929.6 million, down from $1,151.7 million a year ago, as net losses on investments of $858.7 million (driven by $827.7 million of bond losses from rising rates) offset strong core results. P&C underwriting profit stayed robust at $523.9 million with a 92.5% undiscounted combined ratio, and book value per share rose to $1,349.15 from $1,260.19 at year-end 2025.
Key figures
- Eps
- $46.45 basic / $43.32 diluted (Q3 2026); $147.60 basic nine-month
- Revenue
- Insurance revenue of $8,767.8M for Q3 2026; $24,776.8M for first nine months
- Net Income
- $1,096.9M consolidated Q3 net earnings; $929.6M attributable to shareholders (vs. $1,151.7M in Q3 2025)
- Total Debt
- $15,060.1M total debt; $11,416.4M excluding non-insurance companies
- Revenue Yoy
- Q3 insurance revenue up from $8,266.7M YoY (~6%); net premiums written P&C operations +5.4% to $6,907.0M; gross premiums +9.3% to $8,936.9M
- Cash Position
- $1.9B holding company cash and marketable securities; $8.5B subsidiary cash and short-term investments
- Eurolife sale
- approximately $906M, pre-tax gain ~$200M
- Idbi bank stake
- 60.72% for approximately $5.6 billion
- Boots commitment
- up to approximately $2.3 billion of ~$8.9 billion purchase price, 50% equity
- Shares outstanding
- 19,947,166 (down 4.4% from Dec 31, 2025)
- Book value per share
- $1,349.15 vs $1,260.19 at Dec 31, 2025
- Buybacks nine months
- 1,086,435 subordinate voting shares for $1,771.8M
- Underwriting profit q3
- $523.9M vs $540.3M
- Operating income p c q3
- $1,855.2M vs $1,783.5M
- Combined ratio undiscounted
- 92.5% vs 92.0% in Q3 2025
- Total debt to total capital
- 27.3% ex non-insurance companies
- Net losses on investments q3
- -$858.7M (bonds -$827.7M, other -$207.9M, equity +$176.9M)
- Excess fair value over carrying
- $5.1B (from $3.1B at Dec 31, 2025)
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.